Vitamin D receptor (VDR) polymorphism and the risk of acute gvhd after allogeneic haematopoietic stem cell transplantation (HSCT)

被引：0
|
作者：
Bogunia-Kubik, K
Middleton, P
Norden, J
Dickinson, A
Lange, A
机构：
[1] Lower Silesian Ctr Cellular Transplantat, Inst Immunol & Expt Therapy, Wroclaw, Poland
[2] Univ Newcastle, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
来源：
GENES AND IMMUNITY | 2005年 / 6卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [41] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Yok-Lam Kwong
    Annals of Hematology, 2016, 95 : 1191 - 1192
  • [42] Cerebral infections after allogeneic haematopoietic stem cell transplantation
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Keller, MT
    Schulte, C
    Hlinka, M
    Koldehoff, M
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S168 - S168
  • [43] Haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation
    Al Sabty, F.
    Demeckova, E.
    Bojtarova, E.
    Czako, B.
    Hrubisko, M.
    Kubalova, S.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S84 - S84
  • [44] Erythropoietin in anaemias after allogeneic haematopoietic stem cell transplantation
    Stadler, M
    Reuter, C
    Varvenne, M
    Elser, C
    Kamal, H
    Eder, M
    Ganser, A
    Hertenstein, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S186 - S186
  • [45] Safety of pembrolizumab after allogeneic haematopoietic stem cell transplantation
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1191 - 1192
  • [46] Vitamin D Receptor (VDR) gene polymorphism and risk of ischemic stroke
    Puttachandra Prabhakar
    Rita Christopher
    Dindagur Nagaraja
    Molecular Cytogenetics, 7 (Suppl 1)
  • [47] Immune cell regulation by vitamin D3 during allogeneic hematopoietic stem cell transplantation (HSCT)
    Flamann, C.
    Zeun, J.
    Kremer, A.
    Voelkl, S.
    Peter, K.
    Kreutz, M.
    Buettner-Herold, M.
    Kellner, C.
    Saul, D.
    Mougiakakos, D.
    Mackensen, A.
    Bruns, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 54 - 54
  • [48] Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation
    Arai, Y.
    Kanda, J.
    Nakasone, H.
    Kondo, T.
    Uchida, N.
    Fukuda, T.
    Ohashi, K.
    Kaida, K.
    Iwato, K.
    Eto, T.
    Kanda, Y.
    Nakamae, H.
    Nagamura-Inoue, T.
    Morishima, Y.
    Hirokawa, M.
    Atsuta, Y.
    Murata, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 (01) : 96 - 102
  • [49] Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation
    Y Arai
    J Kanda
    H Nakasone
    T Kondo
    N Uchida
    T Fukuda
    K Ohashi
    K Kaida
    K Iwato
    T Eto
    Y Kanda
    H Nakamae
    T Nagamura-Inoue
    Y Morishima
    M Hirokawa
    Y Atsuta
    M Murata
    Bone Marrow Transplantation, 2016, 51 : 96 - 102
  • [50] Telomere length and telomerase reverse transcriptase gene polymorphism as potential markers of complete chimerism and GvHD development after allogeneic haematopoietic stem cell transplantation
    Dratwa-Kuzmin, Marta
    Lacina, Piotr
    Wysoczanska, Barbara
    Kilinska, Dorota
    Siemaszko, Jagoda
    Sobczyk-Kruszelnicka, Malgorzata
    Fidyk, Wojciech
    Solarska, Iwona
    Nasilowska-Adamska, Barbara
    Skowronska, Patrycja
    Bieniaszewska, Maria
    Tomaszewska, Agnieszka
    Basak, Grzegorz
    Giebel, Sebastian
    Bogunia-Kubik, Katarzyna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2025, 151 (03)
12345